AMPHARCO U.S.A Pharmaceutical Joint Stock Company

Ampharco U.S.A JSPC was one of the first pharmaceutical companies in Vietnam to receive in 2004 the WHO-GMP, WHO-GLP and WHO-GSP Drug Manufacturing Certificate.  Its manufacturing facility is based at Nhon Trach 3 Industrial Park in Dong Nai Province.  Its activities over a 50 years span are focused on Research and Development, manufacturing, distribution, marketing, export and import.  With the patients as the core of its business, Ampharco U.S.A  always strives to deliver the highest quality and effective products and services.

News - event
Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage
Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage
We explored the changes in the metabolism of newly synthesized proteoglycan and hyaluronan (HA)...
View more
WHAT IS VITAMIN E?
WHAT IS VITAMIN E?
Vitamin E is one of the many types of nutrient-rich antioxidants available to us in both food and...
Adapalene pretreatment increases follicular penetration of clindamycin
Adapalene pretreatment increases follicular penetration of clindamycin
Adapalene pretreatment increases follicular penetration of clindamycin
Tadalafil are unaffected by the presence of high-fat food
Tadalafil are unaffected by the presence of high-fat food
Both the rate and extent of absorption of tadalafil are unaffected by the presence of high-fat food...

Video clip